PetMed Express Appoints Robyn D'Elia as Chief Financial Officer

PETMED EXPRESS INC

Robyn D'Elia appointed CFO effective September 16, 2024; reports to CEO Sandra Campos.
D'Elia brings 25+ years of finance leadership, including CFO roles at Bed Bath & Beyond (2018-2020) and Odeko (2022-2024).
Employment agreement: 3-year term; base salary $425,000; target annual bonus 75% (max 150%) of base salary.
Initial RSU grant of $1,000,000 divided by reference price (higher of closing price or $4.00), vesting over 3 years.
Press release issued September 12, 2024 announcing the appointment.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robyn D'Elia

Chief Financial Officer

PETS · PETMED EXPRESS INC

Effective: 2024-09-16
Filed: September 12, 2024, 7:59 PM ET

On September 11, 2024, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Robyn D’Elia to serve as the Company’s Chief Financial Officer and to assume the duties of principal financial officer effective September 16, 2024 (“Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robyn D'Elia was appointed as Chief Financial Officer at PETMED EXPRESS INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On September 11, 2024, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Robyn D’Elia to serve as the Company’s Chief Financial Officer and to assume the duties of principal financial officer effective September 16, 2024 (“Effective Date”).

View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-24-000095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.